Cargando…

A cluster‐randomized controlled trial to improve the quality of integrated HIV‐tuberculosis services in primary healthcareclinics in South Africa

INTRODUCTION: : Tuberculosis (TB) remains the most common cause of death among people living with HIV. Integrating HIV and TB services reduces mortality but is sub‐optimally implemented. Quality improvement (QI) methods offer a low‐cost and easily implementable approach to strengthening healthcare d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gengiah, Santhanalakshmi, Barker, Pierre M., Yende‐Zuma, Nonhlanhla, Mbatha, Mduduzi, Naidoo, Shane, Taylor, Myra, Loveday, Marian, Mhlongo, Mesuli, Jackson, Clark, Nunn, Andrew J., Padayatchi, Nesri, Karim, Salim S. Abdool, Naidoo, Kogieleum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426757/ https://www.ncbi.nlm.nih.gov/pubmed/34498370 http://dx.doi.org/10.1002/jia2.25803

Ejemplares similares

Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2017)

Correction to: Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

Organizational contextual factors that predict success of a quality improvement collaborative approach to enhance integrated HIV-tuberculosis services: a sub-study of the Scaling up TB/HIV Integration trial
por: Gengiah, Santhanalakshmi, et al.
Publicado: (2021)

Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

A Quality Improvement Intervention to Inform Scale-Up of Integrated HIV-TB Services: Lessons Learned From KwaZulu-Natal, South Africa
por: Gengiah, Santhanalakshmi, et al.
Publicado: (2021)

Recurrent tuberculosis among HIV-coinfected patients: a case series from KwaZulu-Natal
por: Naidoo, Kogieleum, et al.
Publicado: (2018)

Quality of TB care among people living with HIV: Gaps and solutions
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

High incidence and persistence of hepatitis B virus infection in individuals receiving HIV care in KwaZulu-Natal, South Africa
por: Msomi, Nokukhanya, et al.
Publicado: (2020)

Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa
por: Pillay, Kimesha, et al.
Publicado: (2021)

High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa
por: Naidoo, Kogieleum, et al.
Publicado: (2017)

HIV-Associated Tuberculosis
por: Naidoo, Kogieleum, et al.
Publicado: (2011)

INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial
por: Naidoo, Anushka, et al.
Publicado: (2022)

Detection of differentially culturable tubercle bacteria in sputum from drug-resistant tuberculosis patients
por: Gordhan, Bhavna G., et al.
Publicado: (2022)

A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection
por: Naidoo, Kogieleum, et al.
Publicado: (2018)

TB epidemiology: where are the young women? Know your tuberculosis epidemic, know your response
por: Perumal, Rubeshan, et al.
Publicado: (2018)

Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa
por: Dawood, Halima, et al.
Publicado: (2018)

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
por: Naidoo, Anushka, et al.
Publicado: (2017)

Understanding the Profile of Tuberculosis and Human Immunodeficiency Virus Coinfection: Insights from Expanded HIV Surveillance at a Tuberculosis Facility in Durban, South Africa
por: Perumal, Rubeshan, et al.
Publicado: (2014)

Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field
por: Dookie, Navisha, et al.
Publicado: (2022)

Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes( )
por: Naidoo, Kogieleum, et al.
Publicado: (2022)

Implementation of Adolescent-Friendly Voluntary Medical Male Circumcision Using a School Based Recruitment Program in Rural KwaZulu-Natal, South Africa
por: Montague, Carl, et al.
Publicado: (2014)

Joint modelling of longitudinal and time-to-event data: an illustration using CD4 count and mortality in a cohort of patients initiated on antiretroviral therapy
por: Mchunu, Nobuhle N., et al.
Publicado: (2020)

Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals
por: Chimukangara, Benjamin, et al.
Publicado: (2020)

Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care
por: Dookie, Navisha, et al.
Publicado: (2018)

Tuberculosis: treatment failure, or failure to treat? Lessons from India and South Africa
por: Padayatchi, Nesri, et al.
Publicado: (2019)

Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa
por: Naicker, Nivashnee, et al.
Publicado: (2022)

Improving survival with tuberculosis & HIV treatment integration: A mini-review
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

Individualized Treatment of Multidrug-resistant Tuberculosis Using Whole-Genome Sequencing and Expanded Drug-Susceptibility Testing
por: Dookie, Navisha, et al.
Publicado: (2020)

Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment
por: Perumal, Rubeshan, et al.
Publicado: (2023)

HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services
por: Kharsany, Ayesha BM, et al.
Publicado: (2012)

Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy
por: Darboe, Fatoumatta, et al.
Publicado: (2019)

Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb
por: Naicker, Nikita, et al.
Publicado: (2023)

Acquired HIV drug resistance and virologic monitoring in a HIV hyper-endemic setting in KwaZulu-Natal Province, South Africa
por: Chimukangara, Benjamin, et al.
Publicado: (2021)

CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women
por: Gengiah, Tanuja Narayansamy, et al.
Publicado: (2022)

Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women
por: Joag, Vineet, et al.
Publicado: (2018)

Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy
por: Naranbhai, Vivek, et al.
Publicado: (2014)

Integrated provision of topical pre‐exposure prophylaxis in routine family planning services in South Africa: a non‐inferiority randomized controlled trial
por: Mansoor, Leila E, et al.
Publicado: (2019)

Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study
por: Moosa, Atika, et al.
Publicado: (2019)

Age-Restriction of a Validated Risk Scoring Tool Better Predicts HIV Acquisition in South African Women: CAPRISA 004
por: Castor, Delivette, et al.
Publicado: (2022)

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial
por: Mahomed, Sharana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9hh7p701kc67hi1gkjhih3in9o